The miRNA signatures for IDH-wt glioblastoma and IDH-mutant grades II and III gliomas have been described in serum exosomes and could distinguish preoperative glioblastoma patients from healthy controls with high accuracy [64]. Here, IDH2 is linked to central nervous system cancer.